<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Pharmaceutical Analysis & Statistics in Norway]]></title>
    <link>http://www.reportlinker.com/ci02257/Pharmaceutical.html/coverage/Europe:Norway/mode/premium</link>
    <description><![CDATA[Reportlinker.com Lastest Pharmaceutical Analysis & Statistics in Norway]]></description>
    <pubDate>Sun, 19 May 2013 08:04:33 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Vaccine Market in Norway]]></title>
      <link>http://www.reportlinker.com/p01181890/Vaccine-Market-in-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181890/Vaccine-Market-in-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Norway. The study provides essential market information for decision-makers including: ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Tamro Corporation - Strategic SWOT Analysis Review]]></title>
      <link>http://www.reportlinker.com/p0740809/Tamro-Corporation-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0740809/Tamro-Corporation-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Tamro Corporation (Tamro) is the leading pharmaceutical wholesaler and the largest private pharmacy company in Northern Europe. The company has its wholesale operations in eight countries namely, ...]]></description>
      <pubDate>Thu, 07 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0421724/PHOENIX-Group-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0421724/PHOENIX-Group-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Thu, 07 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[DiaGenic ASA (Symbol:DIAG) SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0428900/DiaGenic-ASA-DIAG-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0428900/DiaGenic-ASA-DIAG-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Thu, 07 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Norda ASA (NORD) - Financial and Strategic SWOT Analysis Review]]></title>
      <link>http://www.reportlinker.com/p01144895/Norda-ASA-NORD-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01144895/Norda-ASA-NORD-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Norda ASA (Norda) formerly NorDiag ASA, is a biotechnology company that develops, manufactures and markets automated sample preparation solutions consisting of instruments and kits for use in the ...]]></description>
      <pubDate>Thu, 07 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Aker BioMarine ASA - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p0466029/Aker-BioMarine-ASA-AKBM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0466029/Aker-BioMarine-ASA-AKBM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Aker BioMarine ASA (Aker BioMarine) is a biotechnology company, based in Norway. The company manufactures, sells, and markets krill based products to animal, human nutrition, and pharmaceutical ...]]></description>
      <pubDate>Wed, 24 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Avexxin AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p01097750/Avexxin-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01097750/Avexxin-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Avexxin AS (Avexxin) is a Norway based pharmaceutical company. It is principally engaged in developing and marketing of small molecule therapeutics for chronic inflammatory conditions. Avexxin ...]]></description>
      <pubDate>Sun, 28 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Nattopharma ASA (NATTO)]]></title>
      <link>http://www.reportlinker.com/p0457820/Nattopharma-ASA-NATTO-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0457820/Nattopharma-ASA-NATTO-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Thu, 14 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Photocure ASA (PHO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p01176786/Photocure-ASA-PHO-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01176786/Photocure-ASA-PHO-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Photocure ASA (Photocure) is a pharmaceutical company. Its operation includes development and marketing of pharmaceuticals and medical devices for the diagnosis and treatment of various types of ...]]></description>
      <pubDate>Thu, 14 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Apokjeden AS in Retailing (Norway)]]></title>
      <link>http://www.reportlinker.com/p01141254/Apokjeden-AS-in-Retailing-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01141254/Apokjeden-AS-in-Retailing-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/119.gif"> Apokjeden AS plans to maintain its position as a leading drugstore chain. Despite a continuing trend of lower prices for pharmaceuticals, the chain is expected to focus on sales of trade items underpinned ...]]></description>
      <pubDate>Sun, 10 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pronova BioPharma ASA (Symbol:PRON) SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0344312/Pronova-BioPharma-ASA-PRON-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0344312/Pronova-BioPharma-ASA-PRON-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Mon, 15 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[SantoSolve AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p01097260/SantoSolve-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01097260/SantoSolve-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary SantoSolve AS (SantoSolve) is a Pharmaceuticals and Healthcare Company, based in Norway. The Company operates through Research and Development (R&D), and Contract Manufacturers. It develops drugs ...]]></description>
      <pubDate>Tue, 29 Jan 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Lytix Biopharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p0466814/Lytix-Biopharma-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0466814/Lytix-Biopharma-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Lytix Biopharma AS (Lytix) is a developmental stage biopharmaceutical company with focus on the development of peptide-based novel antimicrobial drugs in therapeutic area of infections and oncology. ...]]></description>
      <pubDate>Mon, 28 Jan 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[OTC Medications - Norway (2012)]]></title>
      <link>http://www.reportlinker.com/p01079522/OTC-Medications-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01079522/OTC-Medications-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/133.gif"> OTC Medications in Norway by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, ...]]></description>
      <pubDate>Fri, 30 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vitamins & Minerals - Norway (2012)]]></title>
      <link>http://www.reportlinker.com/p01079555/Vitamins-Minerals-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01079555/Vitamins-Minerals-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/133.gif"> Vitamins & Minerals in Norway by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and minerals. ...]]></description>
      <pubDate>Fri, 30 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[BioPhausia AB: Company Capsule]]></title>
      <link>http://www.reportlinker.com/p01049412/BioPhausia-AB-Company-Capsule.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01049412/BioPhausia-AB-Company-Capsule.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1517.gif"> Synopsis Canadean's "BioPhausia AB - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and ...]]></description>
      <pubDate>Thu, 29 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pharmaceuticals - Scandinavia Market Overview (Market size, Segmentation and Trends Analysis) ]]></title>
      <link>http://www.reportlinker.com/p0191855/Pharmaceuticals-Scandinavia-Industry-Guide.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0191855/Pharmaceuticals-Scandinavia-Industry-Guide.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1589.gif">  The report includes easily comparable data on industry value, sector ation, and five forces analysis, plus full five year industry projections for each country. It examines future problems, innovations ...]]></description>
      <pubDate>Thu, 29 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pharmaceuticals - Scandinavia Industry Guide, MarketLine Industry Guides]]></title>
      <link>http://www.reportlinker.com/p01112064/Pharmaceuticals-Scandinavia-Industry-Guide.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01112064/Pharmaceuticals-Scandinavia-Industry-Guide.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1652.gif"> Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. ...]]></description>
      <pubDate>Thu, 29 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pharmaceuticals Market Overview in Norway]]></title>
      <link>http://www.reportlinker.com/p0188612/Pharmaceuticals-in-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0188612/Pharmaceuticals-in-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1589.gif"> It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...]]></description>
      <pubDate>Tue, 20 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Navamedic ASA (Symbol:NAVA) SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0344045/Navamedic-ASA-NAVA-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0344045/Navamedic-ASA-NAVA-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Tue, 06 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Photocure ASA (Symbol:PHO) SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0343386/Photocure-ASA-PHO-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0343386/Photocure-ASA-PHO-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif">  Photocure ASA (Photocure) is engaged in the development and marketing of pharmaceuticals and medical devices for the diagnosis and treatment of various types of cancer and precancerous conditions based ...]]></description>
      <pubDate>Tue, 06 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Algeta ASA - Product Pipeline Review - 2012]]></title>
      <link>http://www.reportlinker.com/p01027471/Algeta-ASA-Product-Pipeline-Review-.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01027471/Algeta-ASA-Product-Pipeline-Review-.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1280.gif"> Algeta ASA - Product Pipeline Review - 2012  Summary  Global Market Direct's pharmaceuticals report, ?Algeta ASA - Product Pipeline Review - 2012? provides data on the Algeta ASA's research and development ...]]></description>
      <pubDate>Tue, 30 Oct 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Epitarget AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p0792345/Epitarget-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0792345/Epitarget-AS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Epitarget AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Epitarget AS (Epitarget) is a Scandinavian life science company, based in Norway. It develops therapeutic products fo ...]]></description>
      <pubDate>Thu, 27 Sep 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Norway Diabetes Care Devices Investment Opportunities, Analysis and Projections to 2017]]></title>
      <link>http://www.reportlinker.com/p0748229/Norway-Diabetes-Care-Devices-Investment-Opportunities-Analysis-and-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0748229/Norway-Diabetes-Care-Devices-Investment-Opportunities-Analysis-and-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1280.gif"> Chile Diabetes Care Devices Investment Opportunities, Analysis and Projections to 2017 What's inside this report?  ?Chile Diabetes Care Devices Investment Opportunities, Analysis and Projections to 2017?, ...]]></description>
      <pubDate>Mon, 24 Sep 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[NorDiag ASA (Symbol:NORD) SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0420282/NorDiag-ASA-NORD-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0420282/NorDiag-ASA-NORD-Financial-and-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Sun, 09 Sep 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Antibiotics Market in Norway to 2016]]></title>
      <link>http://www.reportlinker.com/p0963442/Antibiotics-Market-in-Norway-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0963442/Antibiotics-Market-in-Norway-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Norway. The study provides essential market information for decision-makers ...]]></description>
      <pubDate>Tue, 04 Sep 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vitamins and Provitamins - Norway]]></title>
      <link>http://www.reportlinker.com/p0925454/Vitamins-and-Provitamins-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0925454/Vitamins-and-Provitamins-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report offers a perspective on the actual market situation, trends and future outlook for vitamins and provitamins in Norway. The study provides essential market information for decision-makers ...]]></description>
      <pubDate>Wed, 04 Jul 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication in Norway: Affitech A/S - Product Pipeline Review - H2 2011]]></title>
      <link>http://www.reportlinker.com/p0694215/Affitech-A-S-Product-Pipeline-Review-H2.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0694215/Affitech-A-S-Product-Pipeline-Review-H2.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1280.gif"> The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...]]></description>
      <pubDate>Wed, 27 Jun 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Industry: Lytix Biopharma AS - Product Pipeline Review - Q1 2011]]></title>
      <link>http://www.reportlinker.com/p0547522/Lytix-Biopharma-AS-Product-Pipeline-Review-Q1.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0547522/Lytix-Biopharma-AS-Product-Pipeline-Review-Q1.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1280.gif"> The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...]]></description>
      <pubDate>Wed, 27 Jun 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Analgesics Market Analysis in Norway]]></title>
      <link>http://www.reportlinker.com/p0240841/Analgesics-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0240841/Analgesics-Norway.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/119.gif">  First, Norwegian health authorities believe it is important to let the body build up its natural defences and pain relievers may actually interfere with this process. For example, fevers are considered ...]]></description>
      <pubDate>Wed, 20 Jun 2012 22:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
